Company intelligence
ClearNote Health
Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives.
About ClearNote Health
ClearNote Health – Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives. We focus on developing non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. We apply our proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based changes in biology as cancer develops. With lead programs in non-invasive early detection of pancreatic and ovarian cancers in patients at the highest risk for these diseases. Headquartered in the U.S, the company’s CLIA and CAP-accredited laboratory is located in San Diego, Calif., with additional presence in the San Francisco Bay Area and internationally. #biotechnology #epigenomics #oncology #cancerresearch #cancer
Verified activity
Signals from ClearNote Health
3 published signals
Presence & Recognition
ClearNote Health recognized the American Cancer Society’s Road To Recovery program.
Reported by Micah Collins
People
ClearNote Health recognized Micah Collins, Associate Director of Laboratory Operations, for his commitment to the American Cancer Society’s Road To Recovery program as a Volunteer Driver.
Reported by ClearNote Health
Products & Services
ClearNote Health developed the Avantect Pancreatic Cancer test, a simple blood draw test designed for patients at high risk for pancreatic cancer.
Reported by ClearNote Health